[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343544-105":59,"doc-detail-343544-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-relationship-between-tumor-budding-and-survival-of-patients-with-breast-cancer-a-meta-analysis","The relationship between tumor budding and survival of patients with breast cancer - A meta-analysis","","Tumor budding is explored as a potential prognostic marker, yet its impact on survival outcomes in breast cancer remains insufficiently clear. This meta-analysis pooled cohort evidence to quantify associations with overall survival (OS) and progression-free survival (PFS). A systematic search in PubMed, EMBASE, and Web of Science identified 11 studies with 2828 patients. High tumor budding significantly predicted worse OS and PFS, with supporting subgroup and sensitivity analyses, indicating prognostic value and highlighting the need for standardized evaluation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-relationship-between-tumor-budding-and-survival-of-patients-with-breast-cancer-a-meta-analysis/343544/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-relationship-between-tumor-budding-and-survival-of-patients-with-breast-cancer-a-meta-analysis/343544.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does this meta-analysis address about tumor budding in breast cancer?","Question",{"text":112,"@type":113},"It evaluates whether tumor budding is associated with survival outcomes, specifically overall survival (OS) and progression-free survival (PFS), in breast cancer patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were studies identified for inclusion?",{"text":117,"@type":113},"A comprehensive search was conducted in PubMed, EMBASE, and Web of Science using terms related to tumor budding and breast cancer survival-related outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the pooled results show about high tumor budding and patient prognosis?",{"text":121,"@type":113},"High tumor budding was significantly associated with poorer OS and PFS, with hazard ratios around 1.89 and statistically significant P-values.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343544,1790142023,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","META-ANALYSIS  \nThe relationship between tumor budding and survival of patients with breast cancer: A meta-analysis  \nHongjie Xu 1 and Dajun Wei 2 ∗  \nTumor budding has been proposed as a potential prognostic marker in various cancers, but its association with survival outcomes in breast cancer (BC) remains unclear. This meta-analysis aimed to clarify the relationship between tumor budding and survival outcomesin patients with BC. A comprehensive literature search was conducted in PubMed, EMBASE, and Web of Science. Cohort studies examining the association between tumor budding and overall survival (OS) and progression-free survival (PFS) in BC patients were included. Hazard ratios (HRs) and 95% confidence intervals (CIs) were pooled using a random-effects model to account for potential heterogeneity. Eleven cohort studies, including 2828 patients, met the inclusion criteria. High tumor budding was significantly associated with poorer OS (HR = 1.89, 95% CI = 1.37–2.60, P \u003C 0.001) and PFS (HR = 1.89, 95% CI = 1.32–2.71, P \u003C 0.001). Subgroup analyses revealed a stronger association in studies where high tumor budding was defined as ≥ 10 buds/high-power field (HPF) compared to those with lower cutoffs. Sensitivity analyses confirmed the robustness of the findings. This meta-analysis demonstrates that high tumor budding is associated with significantly worse OS and PFS in BC patients, underscoring its prognostic significance. These findings suggest tumor budding could be a valuable marker in clinical assessments, and further research is needed to standardize its evaluation criteria in BC.  \nKeywords: Tumor budding, breast cancer, BC, survival, prognosis, meta-analysis.  \nIntroduction  \nBreast cancer (BC) is the most commonly diagnosed malignancy and a leading cause of cancer-related mortality among women worldwide [1, 2] . Despite advancements in early detection and treatment, BC remains a signiﬁcant public health burden due to its high prevalence and variability in patient outcomes [3] . Survival rates for BC patients can vary widely based on factors, such as tumor characteristics, treatment modalities, and patient demographics [4–6] . Therefore, identifying reliable prognostic markers and risk factors associated with poor survival is crucial for improving patient management and outcomes. Tumor budding, deﬁned as the presence of isolated single cells or small clusters of up to four cells atthe invasive front of tumors [7–9], has emerged as a potential prognostic marker in various cancers, including colorectal [10], pancreatic [11], and esophageal cancers [12] . The mechanisms underlying tumor budding involve epithelial–mesenchymal transition (EMT), where epithelial cells acquire mesenchymal traits, enhancing their migratory and invasive capabilities [13] . This process contributes to tumor progression, metastasis, and resistance to therapy, ultimately leading to a poorer prognosis [14, 15] . In BC, tumor budding is believed to facilitate metastatic spread by enabling cancer cells to dissociate  \nfrom the primary tumor mass and invade surrounding tissues and distant organs [16] . Evidence has linked tumor budding to several malignant characteristics of BC, such as higher tumor grade, increased lymphovascular invasion, and reduced hormone receptor expression [17, 18] .  \nHowever, previous studies evaluating the association between tumor budding and BC patient survival have shown inconsistent results [19]. Given the potential of tumor budding as a prognostic marker, this meta-analysis aims to systematically evaluate and quantify the relationship between tumor budding and survival outcomes in BC patients. By synthesizing data from multiple cohort studies, we aim to provide a comprehensive understanding of how tumor budding impacts overall survival (OS) and progression-free survival (PFS) in BC patients. This analysis could inform clinical decision making and guide future research on targeted interventions for patients at higher risk ","cbCaivuA4WNhh6Z2","https://ap.wps.com/l/cbCaivuA4WNhh6Z2","pdf",4257235,13,"English","# Introduction\n# Materials and methods\n## Data sources and search strategy\n## Study selection","[{\"question\":\"What question does this meta-analysis address about tumor budding in breast cancer?\",\"answer\":\"It evaluates whether tumor budding is associated with survival outcomes, specifically overall survival (OS) and progression-free survival (PFS), in breast cancer patients.\"},{\"question\":\"How were studies identified for inclusion?\",\"answer\":\"A comprehensive search was conducted in PubMed, EMBASE, and Web of Science using terms related to tumor budding and breast cancer survival-related outcomes.\"},{\"question\":\"What do the pooled results show about high tumor budding and patient prognosis?\",\"answer\":\"High tumor budding was significantly associated with poorer OS and PFS, with hazard ratios around 1.89 and statistically significant P-values.\"}]","The relationship between tumor budding and survival of patients with breast cancer - A meta-analysis | PDF",1790051403,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd2dcf3c1b076841d079f4005d478c5c.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb98ae674942b4f7d47a232c90b54284.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/407570d342708341184e53b92e7771e3.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ec97ef5e714013f946001893ef70b82.webp",980,1268]